XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2
Statements of Operations - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Operating expenses:        
Research and development $ 6,815,708 $ 1,824,502 $ 9,625,499 $ 4,214,085
General and administrative 1,938,447 709,648 5,042,518 1,549,275
Total operating expenses 8,754,155 2,534,150 14,668,017 5,763,360
Operating loss (8,754,155) (2,534,150) (14,668,017) (5,763,360)
Other income:        
Interest income 36,024 2,134 55,673 2,331
Grant income   7,414   36,754
Total other income 36,024 9,548 55,673 39,085
Loss before income taxes (8,718,131) (2,524,602) (14,612,344) (5,724,275)
Income tax expense (benefit) 0 0 0 0
Net loss $ (8,718,131) $ (2,524,602) $ (14,612,344) $ (5,724,275)
Basic loss per common share $ (1.07) $ (0.34) $ (1.79) $ (0.80)
Diluted loss per common share $ (1.07) $ (0.34) $ (1.79) $ (0.80)
Weighted average number of common shares outstanding, basic 8,163,923 7,366,654 8,160,702 7,144,870
Weighted average number of common shares outstanding, diluted 8,163,923 7,366,654 8,160,702 7,144,870